Assenagon Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Assenagon Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,119	Closed	-$708K	–	1524
2023 Q3	$708K	Sell	6,119 -1,193	-16%	-$128K	﹤0.01%	1133
2023 Q2	$752K	Buy	7,312 +64	+0.9%	+$6.75K	﹤0.01%	1037
2023 Q1	$791K	Sell	7,248 -190,475	-96%	-$21.1M	﹤0.01%	1113
2022 Q4	$22.5M	Sell	197,723 -10,481	-5%	-$871K	0.08%	230
2022 Q3	$12.9M	Sell	208,204 -55,309	-21%	-$3.86M	0.05%	296
2022 Q2	$21M	Sell	263,513 -859,737	-77%	-$81.4M	0.08%	222
2022 Q1	$118M	Buy	1,123,250 +1,013,364	+922%	+$98.8M	0.33%	60
2021 Q4	$11.8M	Sell	109,886 -323,475	-75%	-$35.3M	0.03%	292
2021 Q3	$47.5M	Buy	433,361 +364,321	+528%	+$37.8M	0.15%	119
2021 Q2	$6.46M	Buy	+69,040	New	+$6.35M	0.02%	428
2020 Q3	–	Sell	-54,899	Closed	-$3.05M	–	1448
2020 Q2	$3.05M	Buy	+54,899	New	+$2.35M	0.02%	460
2020 Q1	–	Sell	-65,830	Closed	-$2.38M	–	1075
2019 Q4	$2.38M	Buy	+65,830	New	+$2.02M	0.02%	394

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Assenagon Asset Management's HZNP Position: Q4 2023 in Review

Assenagon Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 6,119 shares — an estimated $708K sold.

Assenagon Asset Management first reported a position in HZNP in Q4 2019 and held it in 12 quarters. The position peaked at $118M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Assenagon Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Assenagon Asset Management sold 6,119 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $708K.
Assenagon Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 12 quarters.
Assenagon Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $118M in Q1 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Assenagon Asset Management's 13F filing for Q4 2023, filed 17 Jan 2024.